Related Experiment Video
Updated: Oct 28, 2026

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity
1Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602, USA.
Abstract:
Different antibiotic treatments may affect the survival and physiological responses of Balb/c mice following cecal ligation and puncture (CLP). The broad spectrum imipenem (IMP) was compared with a triple antibiotic mixture of gentamicin, clindamycin, and ciprofloxacin (3AB). Control mice received injections of 5% dextrose (D5W). After CLP with a 25 gauge needle, Mini-Mitters were implanted to measure temperature and activity. Therapy began with 1 mL injections of antibiotics or D5W 2 h post-CLP and continued every 12 h for 3 days. Survival was higher in IMP mice than in 3AB or D5W mice. Starting with the injection 12 h after CLP, 3AB always induced a profound hypothermic response not observed with D5W or IMP. Nocturnal activity levels were higher in IMP mice compared with 3AB or D5W mice during the first night following CLP. To determine the cause of this hypothermic response and to further investigate the acute effects that antibiotic choice may have on murine physiology, the kinetic appearance of IL-1, IL-6, TNF, and KC as well as lipopolysaccharide (LPS), were measured in the plasma and peritoneum of mice sacrificed at 0, .5, and 1.5 h after antibiotic injection at 24 h post-CLP. Cytokine and LPS concentrations in 3AB mice were not significantly different at any of the three time points when compared with IMP or D5W mice. Our data demonstrate that antibiotic therapy consisting of 3AB produces greater morbidity and mortality compared with therapy consisting of IMP. However, the mechanism of these alterations is not due to elevated systemic levels of cytokines or LPS.
Insights
The broad-spectrum antibiotic imipenem (IMP) improved survival in mice after cecal ligation and puncture (CLP) compared to a triple antibiotic mixture (3AB). The 3AB treatment caused hypothermia and increased mortality, but not via elevated cytokines or lipopolysaccharide (LPS).
Area of Science:
- Microbiology and Immunology
- Pharmacology and Therapeutics
- Sepsis and Critical Care Research
Background:
- Antibiotic selection critically influences patient outcomes in sepsis.
- The cecal ligation and puncture (CLP) model is a standard method for inducing polymicrobial sepsis in rodents.
- Understanding antibiotic-specific physiological effects is crucial for optimizing sepsis treatment.
Purpose of the Study:
- To compare the efficacy and physiological impact of imipenem (IMP) versus a triple antibiotic mixture (3AB) in a murine CLP model.
- To investigate the mechanisms behind observed differences in survival and physiological responses, including temperature and activity.
- To assess the role of cytokines and lipopolysaccharide (LPS) in mediating antibiotic-induced effects.
Main Methods:
- Balb/c mice underwent CLP surgery.
- Mice received either IMP, 3AB (gentamicin, clindamycin, ciprofloxacin), or dextrose (D5W) intravenously post-CLP.
- Temperature and activity were monitored using Mini-Mitters; plasma and peritoneal cytokines (IL-1, IL-6, TNF, KC) and LPS were measured at specific time points.
Main Results:
- Survival rates were significantly higher in the IMP group compared to the 3AB and D5W groups.
- The 3AB treatment induced profound hypothermia and reduced nocturnal activity, effects not seen with IMP or D5W.
- No significant differences in cytokine or LPS levels were found between the antibiotic treatment groups.
Conclusions:
- Imipenem (IMP) demonstrates superior outcomes in a murine sepsis model compared to a triple antibiotic regimen (3AB).
- The triple antibiotic mixture (3AB) is associated with increased morbidity and mortality, potentially due to hypothermia and reduced activity.
- The detrimental effects of 3AB are not attributable to elevated systemic cytokine or LPS concentrations.
Related Concept Videos
Microbiota Modulation by Antibiotics
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA

